Related Experiment Video
Updated: Jul 3, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
Sleep disturbances in patients with vasculitis
Misa Tanaka1, Saverio Stranges2, Kathy Speechley1
1Department of Epidemiology and Biostatistics, Western University, Schulich School of Medicine & Dentistry, London, Ontario, Canada.
Sleep disturbances are common in vasculitis patients, affecting over 80%. Modifiable factors like lifestyle and comorbidities, not vasculitis type, are linked to these sleep issues, suggesting targeted interventions can improve quality of life.
Area of Science:
- Rheumatology
- Sleep Medicine
- Public Health
Background:
- Sleep disturbances are understudied in vasculitis patients.
- Limited research exists on sleep health dimensions and risk factors in this population.
- The SleepVasc study addresses this knowledge gap.
Purpose of the Study:
- To evaluate sleep disturbances and sleep health in individuals with vasculitis.
- To identify potential risk factors contributing to sleep problems in vasculitis patients.
- To inform interventions for improving sleep in this demographic.
Main Methods:
- Cross-sectional, web-based survey within the Vasculitis Patient-Powered Research Network.
- Utilized validated questionnaires: Epworth Sleepiness Scale, Functional Outcomes of Sleep Questionnaire-10, Multivariable Apnea Prediction Questionnaire.
- Multivariable regression analyzed associations between sleep disturbances and health behaviors, comorbidities, and vasculitis characteristics.
Main Results:
- 82.2% of participants reported sleep disturbances.
- Obstructive sleep apnea (OSA) was diagnosed in 19.7%, most common in antineutrophil cytoplasmic antibody-associated vasculitis (22.5%).
- Sleep disturbances associated with financial strain, low physical activity, smoking, higher BMI, comorbidities (cardiovascular, psychiatric), vasculitis symptoms, pain, and kidney disease.
Conclusions:
- Sleep disturbances are highly prevalent in patients with vasculitis.
- Focusing on modifiable risk factors is crucial for improving sleep health.
- Interventions targeting lifestyle and comorbidities may enhance health-related quality of life in vasculitis patients.
Related Concept Videos
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
Management of Insomnia
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Vascular Spasm
